258 related articles for article (PubMed ID: 23931807)
21. [The neurological manifestations of Fabry disease. A review].
Firsov KV; Kotov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
[TBL] [Abstract][Full Text] [Related]
22. Fabry's disease.
El-Abassi R; Singhal D; England JD
J Neurol Sci; 2014 Sep; 344(1-2):5-19. PubMed ID: 25106696
[TBL] [Abstract][Full Text] [Related]
23. Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease.
Ohashi T; Iizuka S; Ida H; Eto Y
Mol Genet Metab; 2008 Jul; 94(3):313-8. PubMed ID: 18456533
[TBL] [Abstract][Full Text] [Related]
24. Pathologic endothelial response and impaired function of circulating angiogenic cells in patients with Fabry disease.
Lorenzen JM; Dietrich B; Fiedler J; Jazbutyte V; Fleissner F; Karpinski N; Weidemann F; Wanner C; Asan E; Caprio M; Ertl G; Bauersachs J; Thum T
Basic Res Cardiol; 2013 Jan; 108(1):311. PubMed ID: 23184391
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model.
Lakomá J; Rimondini R; Ferrer Montiel A; Donadio V; Liguori R; Caprini M
Mol Pain; 2016; 12():. PubMed ID: 27531673
[TBL] [Abstract][Full Text] [Related]
26. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
27. Small fiber dysfunction predominates in Fabry neuropathy.
Dütsch M; Marthol H; Stemper B; Brys M; Haendl T; Hilz MJ
J Clin Neurophysiol; 2002 Dec; 19(6):575-86. PubMed ID: 12488789
[TBL] [Abstract][Full Text] [Related]
28. [Fabry disease--a provocation for pediatrics].
Hoffmann B; Mayatepek E
Klin Padiatr; 2006; 218(1):38-40. PubMed ID: 16432775
[TBL] [Abstract][Full Text] [Related]
29. [Peripheral neuropathy in Anderson-Fabry disease: its physiology, evaluation and treatment].
Politei JM; Pagano MA
Rev Neurol; 2004 May 16-31; 38(10):979-83. PubMed ID: 15175982
[TBL] [Abstract][Full Text] [Related]
30. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease.
Schiffmann R; Hauer P; Freeman B; Ries M; Scott LJ; Polydefkis M; Brady RO; McArthur JC; Wagner K
Muscle Nerve; 2006 Jul; 34(1):53-6. PubMed ID: 16583374
[TBL] [Abstract][Full Text] [Related]
31. Fabry disease.
Schiffmann R
Pharmacol Ther; 2009 Apr; 122(1):65-77. PubMed ID: 19318041
[TBL] [Abstract][Full Text] [Related]
32. [Neurological complications of Fabry-disease].
Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development.
Üçeyler N; Biko L; Hose D; Hofmann L; Sommer C
Mol Pain; 2016; 12():. PubMed ID: 27145802
[TBL] [Abstract][Full Text] [Related]
34. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
35. [Anderson-Fabry disease].
Kes P; Basić-Jukić N; Brunetta B; Jurić I
Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573
[TBL] [Abstract][Full Text] [Related]
36. α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease.
Bangari DS; Ashe KM; Desnick RJ; Maloney C; Lydon J; Piepenhagen P; Budman E; Leonard JP; Cheng SH; Marshall J; Thurberg BL
Am J Pathol; 2015 Mar; 185(3):651-65. PubMed ID: 25553976
[TBL] [Abstract][Full Text] [Related]
37. [Fabry disease in Italy: first epidemiologic and collaborative study].
Ricci R; Castorina M; Di Lillo M; Antuzzi D; Frustaci A; Parini R; Menni F; Furlan F; Burlina A; Burlina A; Catuogno S; Gabrielli O; Burattini I; Borsini W; Buchner S; Ferriozzi S; Spisni C; De Vito R; Di Rocco M; Aricò M; Pistone G; Bongiorno AM; Morrone A; Cavicchi C; Zammarchi E
Ann Ital Med Int; 2004; 19(4):269-75. PubMed ID: 15678707
[TBL] [Abstract][Full Text] [Related]
38. Anderson-Fabry disease: developments in diagnosis and treatment.
Kes VB; Cesarik M; Zavoreo I; Madzar Z; Demarin V
Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
[TBL] [Abstract][Full Text] [Related]
39. Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease.
Tavakoli M; Marshall A; Thompson L; Kenny M; Waldek S; Efron N; Malik RA
Muscle Nerve; 2009 Dec; 40(6):976-84. PubMed ID: 19902546
[TBL] [Abstract][Full Text] [Related]
40. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease.
Beck M
Acta Paediatr Suppl; 2006 Apr; 95(451):43-6. PubMed ID: 16720464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
